Status:
COMPLETED
Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to describe the long-term safety of a fixed combination product containing an alternative preservative, dosed once daily for 12 months, in patients with open-angle glaucom...
Eligibility Criteria
Inclusion
- Willing and able to sign an informed consent document.
- Open-angle glaucoma or ocular hypertension who would benefit from a fixed combination medication, in the opinion of the investigator.
- Stable treatment of an IOP-lowering medication.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Pregnant, breastfeeding, or not using adequate birth control.
- Best-corrected visual acuity (BCVA) worse than 55 ETDRS letters.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT00928590
Start Date
July 1 2009
End Date
November 1 2010
Last Update
July 18 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.